CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| University of California, San Diego |
Dr. Lawrence S. B. Goldstein |
Disease Team Research I |
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis |
$5,694,308 |
| University of California, Los Angeles |
Dr. Donald B. Kohn |
Disease Team Research I |
Stem Cell Gene Therapy for Sickle Cell Disease |
$8,833,695 |
| University of California, Los Angeles |
Dr. Irvin SY Chen |
Disease Team Research I |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$9,905,604 |
| ViaCyte, Inc. |
Allan Robins |
Disease Team Research I |
Cell Therapy for Diabetes |
$0 |
| Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Research I |
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy |
$5,560,232 |
| University of California, San Francisco |
Dr. Mitchel S Berger |
Disease Team Research I |
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) |
$6,214,914 |
| City of Hope, Beckman Research Institute |
Prof. Karen S Aboody M.D. |
Disease Team Research I |
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials |
$17,890,623 |
| Stanford University |
Dr. Alfred T Lane |
Disease Team Research I |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,039,208 |
| Stanford University |
Professor Irving L Weissman MD |
Disease Team Research I |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$18,759,276 |
| University of California, Los Angeles |
Dr. Dennis J Slamon |
Disease Team Research I |
Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors |
$19,979,660 |
| City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Disease Team Research I |
ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS |
$14,536,969 |
| University of Southern California |
Mark Salman Humayun |
Disease Team Research I |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$18,904,916 |
| University of California, San Diego |
Dr. Dennis A Carson |
Disease Team Research I |
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
$19,999,826 |
| University of California, San Diego |
Dr. Gene Wei-Ming Yeo |
Basic Biology I |
RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency |
$1,308,901 |
| University of California, San Diego |
Karl H. Willert |
Basic Biology I |
WNT signaling and the control of cell fate decisions in human pluripotent stem cells. |
$1,329,298 |
| University of California, Davis |
Dr. Min Zhao |
Basic Biology I |
Directing migration of human stem cells with electric fields |
$816,228 |
| University of California, Los Angeles |
Dr. Michael A. Teitell |
Basic Biology I |
Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer |
$1,323,029 |
| University of Southern California |
Dr. Martin Pera |
Basic Biology I |
The stem cell microenvironment in the maintenance of pluripotency and reprogramming |
$1,325,723 |
| Stanford University |
Dr. Julien Sage |
Basic Biology I |
The retinoblastoma (RB) gene family in cellular reprogramming |
$1,357,085 |
| Stanford University |
Dr. Susan K McConnell |
Basic Biology I |
Identification and characterization of human ES-derived DA neuronal subtypes |
$1,404,853 |
| University of California, Los Angeles |
Bennett G Novitch |
Basic Biology I |
Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons |
$1,228,278 |
| University of California, Los Angeles |
Dr. Robb Maclellan Dr. |
Basic Biology I |
Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate |
$917,667 |
| University of Southern California |
Dr. Wange Lu |
Basic Biology I |
Defining the molecular mechanisms of somatic cell reprogramming |
$1,365,580 |
| Stanford University |
Professor Helen M. Blau PhD |
Basic Biology I |
Molecular Mechanisms of Reprogramming towards Pluripotency |
$1,408,332 |
| University of California, Los Angeles |
Dr. Luisa Iruela-Arispe |
Basic Biology I |
Molecular Characterization and Functional Exploration of Hemogenic Endothelium |
$1,371,477 |
| University of California, San Francisco |
Dr. Thea D. Tlsty PhD |
SEED Grant |
Role of the tumor suppressor gene, p16INK4a, in regulating stem cell phenotypes in embryonic stem cells and human epithelial cells. |
$614,784 |
| University of California, Irvine |
Dr. Vincent Procaccio |
SEED Grant |
Mitochondrial Dysfunction in Embryonic Stem Cells |
$245,397 |
| University of California, Irvine |
Dr. Grant R MacGregor |
SEED Grant |
Production of Oocytes from Human ES Cells |
$385,466 |
| University of California, Irvine |
Thomas Edward Lane |
SEED Grant |
Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination |
$368,081 |
| Stanford University |
Dr. Aaron J Hsueh |
SEED Grant |
Patient-specific cells with nuclear transfer |
$629,653 |
| University of California, Los Angeles |
Dr. Noriyuki Kasahara |
SEED Grant |
Down-Regulation of Alloreactive Immune Responses to hES Cell-Derived Graft Tissues |
$399,239 |
| Stanford University |
Dr. Joseph C. Wu |
SEED Grant |
In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity |
$623,634 |
| University of California, San Diego |
Dr. Binhai Zheng Dr. |
SEED Grant |
Genetic manipulation of human embryonic stem cells and its application in studying CNS development and repair |
$600,441 |
| Sanford Burnham Prebys Medical Discovery Institute |
Dr. Zhuohua Zhang |
SEED Grant |
Modeling Parkinson’s Disease Using Human Embryonic Stem Cells |
$701,060 |
| Stanford University |
Kenneth Weinberg |
SEED Grant |
Embryonic stem cell-derived thymic epithelial cells |
$628,793 |
| University of Southern California |
Dr. Qilong Ying |
SEED Grant |
Self-renewal of human embryonic stem cells |
$621,421 |
| University of California, Davis |
Professor A. Hari Reddi |
SEED Grant |
hESCs for Articular Cartilage Regeneration |
$301,703 |
| University of California, Los Angeles |
Dr. Hanna Mikkola |
SEED Grant |
Improving microenvironments to promote hematopoietic stem cell development from human embryonic stem cells |
$550,241 |
| University of California, Berkeley |
Ellen Robey |
SEED Grant |
In Vitro Differentiation of T cells from Human Embryonic Stem Cells. |
$477,894 |
| Sanford Burnham Prebys Medical Discovery Institute |
Dr. Robert G. Oshima |
SEED Grant |
Trophoblast differentiation of human ES cells. |
$696,354 |
| Salk Institute for Biological Studies |
Dr. Samuel L Pfaff |
SEED Grant |
Gene regulatory mechanisms that control spinal neuron differentiation from hES cells. |
$704,543 |
| University of California, Los Angeles |
William Lowry |
SEED Grant |
Modeling Human Embryonic Development with Human Embryonic Stem Cells |
$528,096 |
| University of California, Irvine |
Dr. Frank LaFerla |
SEED Grant |
Development of human ES cell lines as a model system for Alzheimer disease drug discovery |
$473,963 |
| University of California, Los Angeles |
Dr. Siavash Kurdistani |
SEED Grant |
Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells |
$549,698 |
| Stanford University |
Dr. Mark Kay Dr. |
SEED Grant |
Novel vectors for gene transfer into human ES cells |
$574,737 |
| Sanford Burnham Prebys Medical Discovery Institute |
Professor Ziwei Huang |
SEED Grant |
New Chemokine-Derived Therapeutics Targeting Stem Cell Migration |
$708,000 |
| University of Southern California |
Dr. David R. Hinton |
SEED Grant |
Therapeutic potential of Retinal Pigment Epithelial cell lines derived from hES cells for retinal degeneration. |
$651,607 |
| Stanford University |
Dr. Susan K McConnell |
SEED Grant |
Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease |
$607,363 |
| Gladstone Institutes, J. David |
Dr. Warner C Greene |
SEED Grant |
The APOBEC3 Gene Family as Guardians of Genome Stability in Human Embryonic Stem Cells |
$717,363 |
| University of California, Los Angeles |
Dr. Zoran Galic |
SEED Grant |
Genetic Enhancement of the Immune Response to Melanoma via hESC-derived T cells |
$616,800 |